20.05.2015
- US pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over the marketing of its antipsychotic drug Risperdal to doctors in the US state of...
27.02.2015
- The Supreme Court of the US state of South Carolina has ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had...
10.08.2011
- Healthcare giant Johnson & Johnson has reached an agreement to settle a single misdemeanor charge related to its antipsychotic treatment Risperdal, the company said in a regulatory...
